Skip to main content
Login
Contact
Subscribe
Search form
Search
The Borger News-Herald
Home
Forms
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Service Directory
Photos
Videos
Games
Entertainment
Calendar
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Amarin Corp Ads
(NQ:
AMRN
)
5.110
USD
+0.030 (+0.59%)
Official Closing Price
Updated: 7:58 PM EDT, Apr 14, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Amarin Corp Ads
< Previous
1
2
3
4
5
6
7
8
9
...
89
90
Next >
Appeals Court Rules Against Amarin in Vascepa Patent Dispute
September 03, 2020
Just one day after hearing arguments, the U.S. Court of Appeals delivered a ruling that Amarin shareholders did not want to hear.
Tags
HIK
AMRN
Market News
From
Motley Fool
Amarin Provides Update Following Ruling in VASCEPA® ANDA Patent Litigation
September 03, 2020
From
GlobeNewswire News Releases
Return On Capital Employed Overview: Amarin Corp
September 03, 2020
Amarin Corp (NASDAQ: AMRN) posted Q2 earnings of $4.16 million, an increase from Q1 of 117.3%. Sales dropped to $135.32 million, a ...
Tags
Market News
Earnings
Benzinga
From
Benzinga
Amarin Shares Have Downside To $3 On Patent Loss, Says Northland
September 03, 2020
An unfavorable Vascepa patent ruling from the Court of Appeals Federal Circuit can place the shares of Amarin in the $3 range, Northland analyst Carl Byrnes tells investors in a research note.
Tags
Stocks / Equities
Pharma/Biotech
From
Blogs - TalkMarkets
52 Biggest Movers From Yesterday
September 03, 2020
Gainers Corcept Therapeutics Incorporated (NASDAQ: CORT) shares jumped 58.5% to close at $19.87 on Wednesday following Form 4 ...
Tags
BRQS
VRA
ADTX
From
Benzinga
Why Amarin Stock Is Getting Slammed Today
September 02, 2020
An appeal hearing for Vascepa's patent case isn't sitting well with investors.
Tags
RDY
HKMP/F
Market News
From
Motley Fool
Amarin plummets 31% after appeal hearing related to its heart drug is 'incrementally negative,' analyst says to not buy shares (AMRN)
September 02, 2020
From
Business Insider
Why Amarin Shares Are Plunging Wednesday
September 02, 2020
Amarin Corporation plc (NASDAQ: AMRN) shares were plummeting on above-average volume as an appeal hearing on the Vascepa fish oil ...
Tags
Vascepa
AMRN
Analyst Ratings
From
Benzinga
44 Stocks Moving In Wednesday's Mid-Day Session
September 02, 2020
Gainers Lonestar Resources US Inc. (NASDAQ: LONE) shares climbed 42.3% to $0.3801 after declining 10% on Tuesday. The company ...
Tags
GRAF
HLNE
Trading Ideas
From
Benzinga
Amarin Sinks After Vascepa Patent Trial Judges Are Revealed
September 02, 2020
Shares of Amarin moved lower after the judges were posted for the company's Federal Circuit appeal of the Vascepa patent invalidation versus generics.
Tags
Healthcare
Stocks / Equities
From
Blogs - TalkMarkets
Thinking about buying stock in Advanced Micro Devices, Lonestar Resources, Amarin Corp, SmileDirectClub, or Vera Bradley?
September 02, 2020
InvestorsObserver issues critical PriceWatch Alerts for AMD, LONE, AMRN, SDC, and VRA.
From
PR Newswire
The Daily Biotech Pulse: Amarin's Vascepa Appeal Hearing, Avid Bioservices' Strong Q1, A Life Sciences Blank Check IPO
September 02, 2020
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) 10X Genomics Inc (NASDAQ: TXG) Acutus Medical Inc (NASDAQ: ...
Tags
TWST
ITOS
EVGN
From
Benzinga
Amarin Supports Latest Clinical Research Evaluating VASCEPA® (Icosapent Ethyl) in Patients with Persistent Cardiovascular Risk Presented at ESC Congress 2020, the Annual Meeting of the European Societ
September 01, 2020
From
GlobeNewswire News Releases
60 Biggest Movers From Yesterday
September 01, 2020
Gainers Aimmune Therapeutics, Inc (NASDAQ: AIMT) shares jumped 171.6% to close at $34.22 on Monday after Nestle SA agreed to ...
Tags
Markets
SHLO
UONE
From
Benzinga
50 Stocks Moving In Monday's Mid-Day Session
August 31, 2020
Gainers Aimmune Therapeutics, Inc (NASDAQ: AIMT) shares climbed 171.5% to $34.21 after Nestle SA agreed to acquire the company at ...
Tags
DXLG
GTX
TAT
From
Benzinga
50 Stocks Moving In Monday's Mid-Day Session
August 31, 2020
Gainers Aimmune Therapeutics, Inc (NASDAQ: AIMT) shares climbed 171.5% to $34.21 after Nestle SA agreed to acquire the company at ...
Tags
Benzinga
BIGC
Penny Stocks
From
Benzinga
Thinking about buying stock in Aimmune Therapeutics, FSD Pharma, Amarin Corp, Trevena Inc, or American Airlines?
August 31, 2020
InvestorsObserver issues critical PriceWatch Alerts for AIMT, HUGE, AMRN, TRVN, and AAL.
From
PR Newswire
38 Stocks Moving in Monday's Pre-Market Session
August 31, 2020
Gainers Aimmune Therapeutics, Inc (NASDAQ: AIMT) shares rose 169.8% to $34.00 in pre-market trading after Nestle SA agreed to ...
Tags
Market News
HJLI
NBIX
From
Benzinga
The Week Ahead In Biotech (Aug. 30- Sept. 5): Bristol-Myers Squibb FDA Decision, Adcom Review For Glaxo, Amarin Vascepa Hearing
August 30, 2020
Biotech stocks went about a consolidation move in the week ended Aug. 28 amid thin news flow. Barringupdates on coronavirus ...
Tags
CUE
Market News
AZN
From
Benzinga
VASCEPA® (Icosapent Ethyl) Reported to Significantly Reduce Coronary Plaque in EVAPORATE Study Final Results Presented at ESC Congress 2020
August 29, 2020
From
GlobeNewswire News Releases
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Featured in Editorial Projecting Significant Growth for Global Brain Tumor Therapeutics Sector
August 27, 2020
From
InvestorBrandNetwork
Global Brain Tumor Therapeutics Market Targeted to Reach $3.4 Billion by 2025
August 27, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Global Brain Tumor Therapeutics Market Targeted to Reach $3.4 Billion by 2025
August 27, 2020
Financialnewsmedia.com News Commentary
From
PR Newswire
Why Amarin's Stock Is Trading Higher Today
August 26, 2020
Amarin Corp (NASDAQ: AMRN) shares are trading higher on Wednesday after Piper Sandler initiated coverage on the company's stock with ...
Tags
Market News
Price Target
why it's moving
From
Benzinga
Benzinga's Top Upgrades, Downgrades For August 26, 2020
August 26, 2020
Upgrades Evercore ISI Group upgraded the previous rating for The Hain Celestial Group Inc (NASDAQ: HAIN) from In-Line to ...
Tags
Market News
top upgrades
AOSL
From
Benzinga
How The Parts Add Up: PPH Headed For $75
August 21, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Cramer Gives His Opinion On Livongo Health, DR Horton And More
August 19, 2020
On CNBC's "Mad Money Lightning Round," Jim Cramer said Livongo Health Inc (NASDAQ: LVGO) is coming back. The merger with ...
Tags
EQT
Media
mad money Lightning Round
From
Benzinga
Latest Clinical Research Evaluating VASCEPA® (Icosapent Ethyl) in Patients with Residual Cardiovascular Risk to be Presented at ESC Congress 2020, the Annual Meeting of the European Society of Cardiol
August 17, 2020
Amarin-Supported Research and Analyses from Academic Collaborators to Be Featured in Five Presentations, Including Late-Breaking Science Presentation of Final EVAPORATE Study Results
From
GlobeNewswire News Releases
Amarin Supports Investigator-Initiated Trial at Kaiser Permanente in the U.S. to Study the Effects of VASCEPA® (icosapent ethyl) in Reducing Viral Upper Respiratory Infections, Including COVID-19 and
August 07, 2020
From
GlobeNewswire News Releases
4 Reasons Amarin Stock Could Tumble Even Further
August 05, 2020
The company's second-quarter earnings report was less than encouraging.
Tags
Market News
AMRN
From
Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
89
90
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.